Summary of Study ST003696

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002294. The data can be accessed directly via it's Project DOI: 10.21228/M83R72 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003696
Study TitleA lipid transport Mla Pqi Chimeric system is essential for Brucella abortus survival in macrophages
Study SummaryThe envelope of diderm bacteria comprises of an inner membrane (IM) and an outer membrane (OM). Several pathways have been recently identified that facilitate the transport of phospholipids between the two membranes in Escherichia coli, including maintaining OM lipid asymmetry (Mla) and paraquat inducible (Pqi) systems. In this study, we report the identification and the characterization of a complex named Mpc in the intracellular pathogen Brucella abortus. Mpc is conserved in numerous species of Hyphomicrobiales and exhibits homology to both the Mla and Pqi systems. Mpc is essential for bacterial growth under conditions of envelope stress and for survival within macrophages during the early stages of infection. Analyses of protein-protein interactions and structural predictions indicate that the Mpc complex bridges IM to OM. The absence of this system results in an altered lipid composition of the OM vesicles, supporting the fact that Mpc plays a role in the transport of lipids between membranes. The discovery of a novel lipid trafficking system enhances the diversity and complexity of known lipid trafficking systems within diderm bacteria.
Institute
CEMBIO
Last NameGarcia
First NameAntonia
AddressUrbanización, 28668 Monteprincipe, Madrid
Emailantogar@ceu.es
Phone913724711
Submit Date2024-10-29
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2025-06-20
Release Version1
Antonia Garcia Antonia Garcia
https://dx.doi.org/10.21228/M83R72
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR002294
Project DOI:doi: 10.21228/M83R72
Project Title:Adaptations to virulence and growth of Brucella abortus envelope
Project Summary:Bacteria of the Brucella genus are collectively responsible for brucellosis, a widely spread zoonosis. Our laboratory developed molecular tools to study growth and virulence of Brucella abortus at the single cell level. Using a genetic approach, we found that B. abortus selected a hybrid Mla-Pqi system (here called Mpc) anchored in the envelope, that is necessary to resist to envelope stress and to infect macrophages. We also found that the main component of the outer membrane, the lipopolysaccharide, is displaying a surprising traffic inside bacteria (the “round trip model”) that we propose to investigate. We also constructed a strain (here called RgsE*) that is growing bipolarly instead of unipolarly and we propose to analyze it to better understand polar ageing and potential polar virulence factors. One such polar virulence factor is the type 4 secretion system VirB, that we found associated to the new pole of the bacterium during macrophage infection. Altogether, our project aims to get a better understanding of envelope growth and properties, especially related to the virulence of B. abortus, with a high potential to generate new concepts that could be applicable to other bacterial pathogens.
Institute:Université de Namur
Last Name:de Bolle
First Name:Xavier
Address:Rue de Bruxelles 61, 5000 Namur, Bélgica
Email:xavier.debolle@unamur.be
Phone:690090778

Subject:

Subject ID:SU003828
Subject Type:Bacteria
Subject Species:Brucella abortus

Factors:

Subject type: Bacteria; Subject species: Brucella abortus (Factor headings shown in green)

mb_sample_id local_sample_id Genotype Sample source
SA403949BLEBS_2_posmcpA-knockout OMVs
SA403950BLEBS_2_negmcpA-knockout OMVs
SA403951WHOLE CELLS_8_negmcpA-knockout Whole cells
SA403952WHOLE CELLS_8_posmcpA-knockout Whole cells
SA403953BLEBS_3_negmcpD-knockout OMVs
SA403954BLEBS_3_posmcpD-knockout OMVs
SA403955WHOLE CELLS_9_posmcpD-knockout Whole cells
SA403956WHOLE CELLS_9_negmcpD-knockout Whole cells
SA403957BLEBS_4_posmcpE-knockout OMVs
SA403958BLEBS_4_negmcpE-knockout OMVs
SA403959WHOLE CELLS_10_posmcpE-knockout Whole cells
SA403960WHOLE CELLS_10_negmcpE-knockout Whole cells
SA403961BLEBS_5_negmcpF-knockout OMVs
SA403962BLEBS_5_posmcpF-knockout OMVs
SA403963WHOLE CELLS_11_posmcpF-knockout Whole cells
SA403964WHOLE CELLS_11_negmcpF-knockout Whole cells
SA403945BLEBS_6_posmcp-fullcomplex-knockout OMVs
SA403946BLEBS_6_negmcp-fullcomplex-knockout OMVs
SA403947WHOLE CELLS_12_posmcp-fullcomplex-knockout Whole cells
SA403948WHOLE CELLS_12_negmcp-fullcomplex-knockout Whole cells
SA403941BLEBS_1_posWild-type OMVs
SA403942BLEBS_1_negWild-type OMVs
SA403943WHOLE CELLS_7_posWild-type Whole cells
SA403944WHOLE CELLS_7_negWild-type Whole cells
Showing results 1 to 24 of 24

Collection:

Collection ID:CO003821
Collection Summary:Lipids were extracted using a modified procedure inspired by earlier methods (Bligh & Dyer, 1959, https://doi.org/10.1139/o59-099; Daniels et al., 1993, https://doi.org/10.1128/9781555817497.ch18). In summary, 500 µL of bacterial or outer membrane vesicle (OMV) suspensions (20 mg of lyophilized material) in deionized water were combined with 650 µL of chloroform and 1300 µL of methanol. The mixture was vortexed for 3 hours, after which 650 µL of chloroform and 650 µL of deionized water were added and gently mixed for 30 minutes. Phase separation was achieved through brief centrifugation, and the organic layer was isolated and dried under a nitrogen stream. For OMV isolation, cultures of 800 mL were grown for 48 hours, treated with 0.5% phenol to inactivate them, and then centrifuged at 8,200 × g for 20 minutes at 4°C. The pellet was retained, while the supernatant was processed using a Pellicon® tangential flow filtration system with a 100 kDa membrane to concentrate it. Afterward, the concentrated supernatant was centrifuged again under the same conditions to remove any solid particles. To encourage the aggregation of OMVs, the supernatant was frozen at -20°C, thawed, and then ultracentrifuged at 47,000 × g for 3 hours at 4°C. The resulting pellet, containing the OMVs, was resuspended in deionized water, dialyzed at 4°C for three days, and stored at -80°C. Both the pellet from the culture and the OMV suspension were freeze-dried using a TELSTAR CRYODOS 50 lyophilizer. For additional information of isolation of OMV or sample treatment bacteria prior to extraction refer to doi: https://doi.org/10.1101/2024.10.31.621289
Sample Type:bacterial cells, outer membrane vesicles

Treatment:

Treatment ID:TR003837
Treatment Summary:No treatment, since this is a genotype study where knockouts were compared. For the methodology to generate the specific knockouts of the MPC complex, please refer to doi: https://doi.org/10.1101/2024.10.31.621289

Sample Preparation:

Sampleprep ID:SP003835
Sampleprep Summary:Lipid residues from whole bacteria or OMVs, prepared following the Bligh and Dyer method, were dissolved in 300 µL of a methanol:chloroform solution containing 25 mg/L of d17:0 sphinganine (IS1). Lipids were further extracted by vortexing the mixture at room temperature for 20 minutes. The resulting extracts were transferred to individual LC-MS vials, where 20 µL of the SPLASH Lipidomix® lipid standard mix (IS2, Avanti Polar Lipids, CA, USA) were added. Samples were then dried completely using a vacuum concentrator at 37°C. Finally, the residues were re-extracted in 100 µL of methanol:chloroform (2:1, v/v) with thorough vortexing for 30 minutes at room temperature before analysis.

Chromatography:

Chromatography ID:CH004608
Chromatography Summary:The chromatographic method is the one comprehensively described in doi: 10.1016/j.jlr.2024.100671 and adapted from Agilent Lipid Annotator application note (see https://www.agilent.com/cs/library/applications/application-6546-q-tof-lipidome-5994-0775en-agilent.pdf)
Instrument Name:Agilent 1290 HPLC
Column Name:Agilent InfinityLab Poroshell 120 EC-C18 (100 x 3.0mm, 2.7um) with guard column Agilent InfinityLab Poroshell 120 EC-C18 (5 x 3.0mm, 2.7um)
Column Temperature:50
Flow Gradient:Time (min)/%B: 0.00/70, 1.00/70, 3.50/86, 10.00/86 11.00/100, 17.00/100, 17.10/70, 19.00/70
Flow Rate:0.6 mL/min
Solvent A:90% water/10% methanol; 10 mM ammonium acetate; 0.2 mM ammonium fluoride
Solvent B:20% acetonitrile/30% methanol/50% isopropanol10 mM ammonium acetate; 0.2 mM ammonium fluoride
Chromatography Type:Reversed phase

Analysis:

Analysis ID:AN006064
Analysis Type:MS
Chromatography ID:CH004608
Has Rt:1
Rt Units:Minutes
Results File:ST003696_AN006064_Results.txt
Units:amu
  
Analysis ID:AN006065
Analysis Type:MS
Chromatography ID:CH004608
Has Rt:1
Rt Units:Minutes
Results File:ST003696_AN006065_Results.txt
Units:amu
  logo